Herbalife Ltd. (NYSE:HLF) Given Average Recommendation of “Reduce” by Brokerages

Shares of Herbalife Ltd. (NYSE:HLFGet Free Report) have received an average recommendation of “Reduce” from the five research firms that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating and four have issued a hold rating on the company. The average 12-month target price among brokerages that have covered the stock in the last year is $10.70.

Several analysts recently commented on the company. Bank of America dropped their price objective on Herbalife from $10.00 to $8.00 and set an “underperform” rating on the stock in a research note on Thursday, March 21st. DA Davidson reiterated a “neutral” rating and set a $9.50 price objective on shares of Herbalife in a report on Thursday, May 2nd. StockNews.com raised Herbalife from a “hold” rating to a “buy” rating in a research note on Wednesday, July 3rd. Finally, Mizuho lifted their price target on shares of Herbalife from $10.00 to $11.00 and gave the company a “neutral” rating in a research note on Friday, June 7th.

Get Our Latest Stock Analysis on HLF

Insider Activity at Herbalife

In other Herbalife news, Director Donal L. Mulligan purchased 30,000 shares of the firm’s stock in a transaction dated Friday, May 3rd. The stock was bought at an average cost of $9.65 per share, with a total value of $289,500.00. Following the purchase, the director now directly owns 60,000 shares of the company’s stock, valued at $579,000. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. In related news, Director Juan Miguel Mendoza bought 7,000 shares of the stock in a transaction that occurred on Friday, May 10th. The shares were acquired at an average price of $10.65 per share, with a total value of $74,550.00. Following the completion of the transaction, the director now owns 93,279 shares in the company, valued at $993,421.35. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Donal L. Mulligan purchased 30,000 shares of Herbalife stock in a transaction that occurred on Friday, May 3rd. The shares were bought at an average cost of $9.65 per share, with a total value of $289,500.00. Following the completion of the transaction, the director now directly owns 60,000 shares of the company’s stock, valued at approximately $579,000. The disclosure for this purchase can be found here. In the last quarter, insiders have bought 42,500 shares of company stock valued at $418,485. 0.94% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in HLF. GAMMA Investing LLC grew its holdings in Herbalife by 465.3% during the second quarter. GAMMA Investing LLC now owns 3,533 shares of the company’s stock worth $37,000 after purchasing an additional 2,908 shares during the period. Public Employees Retirement System of Ohio lifted its position in shares of Herbalife by 22.9% in the first quarter. Public Employees Retirement System of Ohio now owns 5,558 shares of the company’s stock valued at $56,000 after buying an additional 1,035 shares during the last quarter. Foundry Partners LLC bought a new position in shares of Herbalife during the 1st quarter worth approximately $105,000. Platinum Investment Management Ltd. increased its holdings in shares of Herbalife by 68.0% during the 1st quarter. Platinum Investment Management Ltd. now owns 11,374 shares of the company’s stock worth $114,000 after acquiring an additional 4,603 shares during the last quarter. Finally, Lazard Asset Management LLC raised its stake in Herbalife by 140.3% in the 1st quarter. Lazard Asset Management LLC now owns 12,040 shares of the company’s stock valued at $121,000 after acquiring an additional 7,030 shares during the period.

Herbalife Trading Down 4.5 %

NYSE HLF opened at $10.71 on Tuesday. Herbalife has a 12 month low of $6.68 and a 12 month high of $19.48. The stock has a 50-day simple moving average of $10.77 and a 200 day simple moving average of $10.65. The company has a market capitalization of $1.07 billion, a PE ratio of 7.82 and a beta of 1.25.

Herbalife (NYSE:HLFGet Free Report) last announced its quarterly earnings results on Wednesday, May 1st. The company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.12. The company had revenue of $1.30 billion during the quarter, compared to analysts’ expectations of $1.26 billion. Herbalife had a negative return on equity of 19.97% and a net margin of 2.70%. Herbalife’s revenue was up 3.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.54 EPS. As a group, sell-side analysts predict that Herbalife will post 1.48 earnings per share for the current fiscal year.

Herbalife Company Profile

(Get Free Report

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.

Read More

Analyst Recommendations for Herbalife (NYSE:HLF)

Receive News & Ratings for Herbalife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife and related companies with MarketBeat.com's FREE daily email newsletter.